Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes

Thomas, MK; Nikooienejad, A; Bray, R; Cui, XW; Wilson, J; Duffin, K; Milicevic, Z; Haupt, A; Robins, DA

Thomas, MK (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021; 106 (2): 388

Abstract

Context: Novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA) tirzepatide demonstra......

Full Text Link